uniQure N.V. (QURE) is listed on NASDAQ in Pharmaceutical Stocks. It is $48.69, -1.76%, with a $3.1B market cap. RSI is 60.7, near overbought. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 60.7 Near Overbought
Market Cap $3.1B
Volume 557.6K
Fundamentals — 10-Q Q1 2026
Revenue $3.6M
Net Income $-53.5M
EPS $-0.85
Gross Margin 93.9%
Operating Margin -1283.5%
Net Margin -1502.9%
Debt / Equity 0.3x
P/E Ratio -57.3x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Kapusta Matthew C | CEO, Managing Director | Sell | 21,082 | $45.16 | $952,051 | 2026 Jul 2 |
| Abi-saab Walid | Chief Medical Officer | Sell | 30,000 | $46.42 | $1.4M | 2026 Jun 30 |
| Kaye Jack | Director | Sell | 21,167 | $46.44 | $983,030 | 2026 Jun 30 |
| Abi-saab Walid | Chief Medical Officer | Sell | 1,434 | $46.86 | $67,197 | 2026 Jun 26 |
| Kapusta Matthew C | CEO, Managing Director | Sell | 35,412 | $50.02 | $1.8M | 2026 Jun 25 |
| Kapusta Matthew C | CEO, Managing Director | Sell | 206,100 | $45.47 | $9.4M | 2026 Jun 18 |
| Balachandran Madhavan | Director | Sell | 11,685 | $45.06 | $526,485 | 2026 Jun 17 |
| Kaye Jack | Director | Sell | 5,295 | $42.57 | $225,408 | 2026 Jun 17 |
| Balachandran Madhavan | Director | Sell | 10,000 | $27.85 | $278,500 | 2026 Jun 15 |
| Potts Jeannette | Chief Legal Officer | Sell | 5,237 | $27.67 | $144,908 | 2026 Jun 15 |
| Meek David D. | Director | Sell | 1,993 | $27.06 | $53,931 | 2026 Jun 11 |
| Gut Robert | Director | Sell | 10,278 | $26.32 | $270,486 | 2026 Jun 11 |
| O'keefe Kylie | Chief Customer & Strat Officer | Sell | 15,936 | $27.06 | $431,228 | 2026 Jun 11 |
| Springhorn Jeremy P. | Director | Sell | 1,993 | $27.06 | $53,931 | 2026 Jun 11 |
| Post Leonard E | Director | Sell | 1,993 | $27.06 | $53,931 | 2026 Jun 11 |
| Kaye Jack | Director | Sell | 1,993 | $27.06 | $53,931 | 2026 Jun 11 |
| Jacques Rachelle Suzanne | Director | Sell | 1,993 | $27.06 | $53,931 | 2026 Jun 11 |
| Balachandran Madhavan | Director | Sell | 1,993 | $27.06 | $53,931 | 2026 Jun 11 |
| Kaye Jack | Director | Sell | 2,645 | $30.01 | $79,376 | 2026 Jun 3 |
| Abi-saab Walid | Chief Medical Officer | Sell | 45,000 | $25.06 | $1.1M | 2026 May 8 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $67.67 | 38.4 | $6.1B |
| | $97.41 | 36.9 | $6.3B |
| | $59.99 | 39.6 | $5.8B |
Take QURE further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put QURE in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when uniQure N.V. next reports.
Set alerts on QURE
Get notified when uniQure N.V. hits your price targets or technical conditions are met.
Get Started Free